These tools will no longer be maintained as of December 31, 2024. Archived website can be found here. PubMed4Hh GitHub repository can be found here. Contact NLM Customer Service if you have questions.


BIOMARKERS

Molecular Biopsy of Human Tumors

- a resource for Precision Medicine *

156 related articles for article (PubMed ID: 34088020)

  • 21. In situ detection of apolipoprotein E epsilon 4 in archival human brain.
    Saito Y; Ruberu NN; Harada M; Arai T; Sawabe M; Nukina N; Murayama S
    Neuroreport; 2004 May; 15(7):1113-5. PubMed ID: 15129156
    [TBL] [Abstract][Full Text] [Related]  

  • 22. Establishment of SIAISi002-A, an induced pluripotent stem cell (iPSC) line from 39-year old healthy female donor with a family history of Alzheimer's disease (AD) and two copies of APOE4 gene.
    Yan Y; Qiu Y; Zhao A; Zhao J; Wang Y; Deng Y
    Stem Cell Res; 2020 May; 45():101792. PubMed ID: 32339902
    [TBL] [Abstract][Full Text] [Related]  

  • 23. Apolipoprotein E epsilon4 association with dementia in a population-based study: The Framingham study.
    Myers RH; Schaefer EJ; Wilson PW; D'Agostino R; Ordovas JM; Espino A; Au R; White RF; Knoefel JE; Cobb JL; McNulty KA; Beiser A; Wolf PA
    Neurology; 1996 Mar; 46(3):673-7. PubMed ID: 8618665
    [TBL] [Abstract][Full Text] [Related]  

  • 24. Relation of apolipoprotein E polymorphism to clinically diagnosed Alzheimer's disease in the Korean population.
    Kim HC; Kim DK; Choi IJ; Kang KH; Yi SD; Park J; Park YN
    Psychiatry Clin Neurosci; 2001 Apr; 55(2):115-20. PubMed ID: 11285089
    [TBL] [Abstract][Full Text] [Related]  

  • 25. Apolipoprotein E polymorphism and age of onset for Alzheimer's disease in a bi-ethnic sample.
    Harwood DG; Barker WW; Ownby RL; St George-Hyslop P; Mullan M; Duara R
    Int Psychogeriatr; 2004 Sep; 16(3):317-26. PubMed ID: 15559755
    [TBL] [Abstract][Full Text] [Related]  

  • 26. Brain integrity is altered by hepatic APOE ε4 in humanized-liver mice.
    Giannisis A; Patra K; Edlund AK; Nieto LA; Benedicto-Gras J; Moussaud S; de la Rosa A; Twohig D; Bengtsson T; Fu Y; Bu G; Bial G; Foquet L; Hammarstedt C; Strom S; Kannisto K; Raber J; Ellis E; Nielsen HM
    Mol Psychiatry; 2022 Aug; 27(8):3533-3543. PubMed ID: 35418601
    [TBL] [Abstract][Full Text] [Related]  

  • 27. Apolipoprotein E epsilon4 allele and familial aggregation of Alzheimer disease.
    Martinez M; Campion D; Brice A; Hannequin D; Dubois B; Didierjean O; Michon A; Thomas-Anterion C; Puel M; Frebourg T; Agid Y; Clerget-Darpoux F
    Arch Neurol; 1998 Jun; 55(6):810-6. PubMed ID: 9626772
    [TBL] [Abstract][Full Text] [Related]  

  • 28. Association between apolipoprotein E epsilon4 allele and apathy in probable Alzheimer's disease.
    Monastero R; Mariani E; Camarda C; Ingegni T; Averna MR; Senin U; Camarda R; Mecocci P
    Acta Psychiatr Scand; 2006 Jan; 113(1):59-63. PubMed ID: 16390371
    [TBL] [Abstract][Full Text] [Related]  

  • 29. Apolipoprotein E genotype regulates amyloid-beta cytotoxicity.
    Wilhelmus MM; Otte-Höller I; Davis J; Van Nostrand WE; de Waal RM; Verbeek MM
    J Neurosci; 2005 Apr; 25(14):3621-7. PubMed ID: 15814793
    [TBL] [Abstract][Full Text] [Related]  

  • 30. Genome-wide analysis identified abundant genetic modulators of contributions of the apolipoprotein E alleles to Alzheimer's disease risk.
    Nazarian A; Loika Y; He L; Culminskaya I; Kulminski AM
    Alzheimers Dement; 2022 Nov; 18(11):2067-2078. PubMed ID: 34978151
    [TBL] [Abstract][Full Text] [Related]  

  • 31. Apolipoprotein E as a Therapeutic Target in Alzheimer's Disease: A Review of Basic Research and Clinical Evidence.
    Yamazaki Y; Painter MM; Bu G; Kanekiyo T
    CNS Drugs; 2016 Sep; 30(9):773-89. PubMed ID: 27328687
    [TBL] [Abstract][Full Text] [Related]  

  • 32. Risk of Alzheimer disease with the epsilon4 allele for apolipoprotein E in a population-based study of men aged 62-73 years.
    Breitner JC; Jarvik GP; Plassman BL; Saunders AM; Welsh KA
    Alzheimer Dis Assoc Disord; 1998 Mar; 12(1):40-4. PubMed ID: 9539409
    [TBL] [Abstract][Full Text] [Related]  

  • 33. APOE ε2 resilience for Alzheimer's disease is mediated by plasma lipid species: Analysis of three independent cohort studies.
    Wang T; Huynh K; Giles C; Mellett NA; Duong T; Nguyen A; Lim WLF; Smith AA; Olshansky G; Cadby G; Hung J; Hui J; Beilby J; Watts GF; Chatterjee P; Martins I; Laws SM; Bush AI; Rowe CC; Villemagne VL; Ames D; Masters CL; Taddei K; Doré V; Fripp J; Arnold M; Kastenmüller G; Nho K; Saykin AJ; Baillie R; Han X; Martins RN; Moses EK; Kaddurah-Daouk R; Meikle PJ
    Alzheimers Dement; 2022 Nov; 18(11):2151-2166. PubMed ID: 35077012
    [TBL] [Abstract][Full Text] [Related]  

  • 34. The epsilon2 and epsilon4 alleles of the apolipoprotein gene are associated with age-related macular degeneration.
    Baird PN; Guida E; Chu DT; Vu HT; Guymer RH
    Invest Ophthalmol Vis Sci; 2004 May; 45(5):1311-5. PubMed ID: 15111582
    [TBL] [Abstract][Full Text] [Related]  

  • 35. Apolipoprotein E polymorphism in elderly Chilean people with Alzheimer's disease.
    Quiroga P; Calvo C; Albala C; Urquidi J; Santos JL; Pérez H; Klaassen G
    Neuroepidemiology; 1999; 18(1):48-52. PubMed ID: 9831815
    [TBL] [Abstract][Full Text] [Related]  

  • 36. Apolipoprotein E and Alzheimer disease: genotype-specific risks by age and sex.
    Bickeböller H; Campion D; Brice A; Amouyel P; Hannequin D; Didierjean O; Penet C; Martin C; Pérez-Tur J; Michon A; Dubois B; Ledoze F; Thomas-Anterion C; Pasquier F; Puel M; Demonet JF; Moreaud O; Babron MC; Meulien D; Guez D; Chartier-Harlin MC; Frebourg T; Agid Y; Martinez M; Clerget-Darpoux F
    Am J Hum Genet; 1997 Feb; 60(2):439-46. PubMed ID: 9012418
    [TBL] [Abstract][Full Text] [Related]  

  • 37. Generation of a set of isogenic, gene-edited iPSC lines homozygous for all main APOE variants and an APOE knock-out line.
    Schmid B; Prehn KR; Nimsanor N; Garcia BIA; Poulsen U; Jørring I; Rasmussen MA; Clausen C; Mau-Holzmann UA; Ramakrishna S; Muddashetty R; Steeg R; Bruce K; Mackintosh P; Ebneth A; Holst B; Cabrera-Socorro A
    Stem Cell Res; 2019 Jan; 34():101349. PubMed ID: 30660866
    [TBL] [Abstract][Full Text] [Related]  

  • 38. Association of APOE epsilon2/epsilon3/epsilon4 and promoter gene variants with dementia but not cardiovascular mortality in old age.
    Heijmans BT; Slagboom PE; Gussekloo J; Droog S; Lagaay AM; Kluft C; Knook DL; Westendorp RG
    Am J Med Genet; 2002 Jan; 107(3):201-8. PubMed ID: 11807900
    [TBL] [Abstract][Full Text] [Related]  

  • 39. The association between the ApoE polymorphisms and the MRI-defined intracranial lesions in a cohort of southern China population.
    Li Z; Yang N; Lei X; Lin C; Li N; Jiang X; Wei X; Xu B
    J Clin Lab Anal; 2019 Sep; 33(7):e22950. PubMed ID: 31199015
    [TBL] [Abstract][Full Text] [Related]  

  • 40. Decreased frequency of apolipoprotein E epsilon4 allele from Northern to Southern Europe in Alzheimer's disease patients and centenarians.
    Panza F; Solfrizzi V; Torres F; Mastroianni F; Del Parigi A; Colacicco AM; Basile AM; Capurso C; Noya R; Capurso A
    Neurosci Lett; 1999 Dec; 277(1):53-6. PubMed ID: 10643896
    [TBL] [Abstract][Full Text] [Related]  

    [Previous]   [Next]    [New Search]
    of 8.